Acute anti-ischemic effect of testosterone in men with coronary artery disease

Circulation

Volumn 99, Issue 13, 1999, Pages 1666-1670

  Rosano, Giuseppe M C ^a,b   Leonardo, Filippo ^a   Pagnotta, Paolo ^a   Pelliccia, Francesco ^a   Panina, Gaia ^a   Cerquetani, Elena ^a   Della Monica, Paola Lilla ^a   Bonfigli, Bruno ^a   Volpe, Massimo ^a   Chierchia, Sergio L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Coronary disease; Exercise; Heart diseases; Hormones; Ischemia

Indexed keywords

ESTRADIOL; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; TESTOSTERONE BLOOD LEVEL;

EID: 0033528723     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.13.1666     Document Type: Article

References (17)

1. Sorva R, Kuusi T, Taskinen MR, Perheentupa J, Nikkila EA. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis. 1988;69:191-197.
2. Jones DB, Higgins B, Billet JS, Price WH, Edwards CR, Beastall GH, Sheperd J, Sweeting VM, Horn DB, Wenham PR. The effect of testosterone replacement on plasma lipids and apolipoproteins. Eur J Clin Invest. 1989;19:438-441.
3. Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T. Endogenous testosterone, fibrinolysis and coronary heart disease risk in hyperlipidemic men. J Lab Clin Med. 1993;122:412-420.
4. Uyanik BS, Ari Z, Gumus B, Yigitoglu MR, Arslan T. Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men: a placebo controlled study. Jpn Heart J. 1997;38:73-82.
5. Bonnel RW, Pritchett CP, Rardin TE. Treatment of angina pectoris and coronary artery disease with sex hormones. Ohio State Med J. 1941;37: 554-556.
6. Hamm L. Testosterone propionate in the treatment of angina pectoris. J Clin Endocrinol. 1942;2:325-328.
7. Lesser MA. The treatment of angina pectoris with testosterone propionate: preliminary report. N Engl J Med. 1942;226:51-54.
8. Lesser MA. The treatment of angina pectoris with testosterone propionate: further observations. N Engl J Med. 1943;228:185-188.
9. Sigler LH, Tulgan J. Treatment of angina pectoris by testosterone. N Y State J Med. 1943;43:1424-1428.
10. Strong GF, Wallace W. Treatment of angina pectoris and peripheral vascular disease with sex hormones. Can Med Assoc J. 1944;50:30-33.
11. Waldman S. The treatment of angina pectoris with testosterone propionate. J Clin Endocrinol. 1945;5:305-317.
12. Walker TC. The use of testosterone propionate and estrogenic substance in treatment of essential hypertension, angina pectoris and peripheral vascular disease. J Clin Endocrinol. 1942;2:560-568.
13. Jaffe MD. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J. 1977;39:1217-1222.
14. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91: 1154-1160.
15. Lesser MA. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol. 1946;6:549-557.
16. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133-136.
17. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeil J, Poole-Wilson PA. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24-30.